Efficacy and Safety Evaluation of SMO1 in Patients With Retinal Vein Occlusive Macular Edema

NCT07708142 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

312

Enrollment

INDUSTRY

Sponsor class

Conditions

Retinal Vein Occlusion With Macular Edema

Interventions

DRUG: Reference Drug
DRUG: SMO1

Sponsor

SANGMYUNG innovation